Liver cancer stem cells

Journal of Clinical Oncology

Volumn 26, Issue 17, 2008, Pages 2800-2805

  Sell, Stewart ^a   Leffert, Hyam L ^a  

^a ORDWAY RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MOLECULAR MARKER;

CANCER RESISTANCE; CANCER STEM CELL; CANCER TRANSPLANTATION; CELL DIFFERENTIATION; CELL POPULATION; CELL PROLIFERATION; CELL RENEWAL; HEPATOBLASTOMA; HUMAN; LIVER CANCER; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; MORRIS HEPATOMA; PRIORITY JOURNAL; REVIEW; ANIMAL; CELL TRANSFORMATION; CHEMICALLY INDUCED DISORDER; INTRAHEPATIC BILE DUCT; LIVER REGENERATION; LIVER TUMOR; PATHOLOGY; PATHOPHYSIOLOGY; PRECANCER;

ANIMALS; BILE DUCTS, INTRAHEPATIC; CARCINOMA, HEPATOCELLULAR; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; HEPATOBLASTOMA; HUMANS; LIVER NEOPLASMS; LIVER NEOPLASMS, EXPERIMENTAL; LIVER REGENERATION; NEOPLASTIC STEM CELLS; PRECANCEROUS CONDITIONS;

EID: 45549084904     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.15.5945     Document Type: Review

References (93)

1. Sell S, Pierce GB: Maturation arrest of stem cell differentiation is a common pathway for the cellular origin of teratocarcinomas and epithelial cancers. Lab Invest 70:6-22, 1994
2. Sell S: Stem cell origin of cancer and differentiation therapy. Crit Rev Oncology Hematology 52:1-28, 2004
3. Sell S, Leffert HL: An evaluation of cellular lineages in the pathogenesis of experimental hepatocellular carcinoma. Hepatology 2:77-86, 1982
4. Sell S, Dunsford H: Evidence for the stem cell origin of hepatocellular carcinoma and cholangiocarcinoma. Am. J Pathol 134:1347-1363, 1989
5. Sell S: Cellular origin of hepatocellular carcinoma. Cell Develop Biology 13:419-424, 2002
6. Sell S: Stem cells in hepatocarcinogenesis. Cell Science Reviews, ISN NO 1742-8130, 2006
7. Pierce GB, Spears WC: Tumors as caricatures of the process of tissue renewal: Prospects for therapy by directing differentiation. Cancer Res 48:1196-1204, 1988
8. Reya T, Morrison SJ, Clarke MF, et al: Stem cells, cancer, and cancer stem cells. Nature 414:105-111, 2001
9. Wicha MS, Liu S, Dontu G: Cancer stem cells: An old idea - a paradigm shift. Cancer Res 66:1883-1890, 2006
10. Sell S: Leukemia: Stem cells, maturation arrest and differentiation therapy. Stem Cell Reviews 1:197-205, 2005
11. Sell S: Cancer stem cells and differentiation therapy. Tumor Biology 27:59-70, 2006
12. Sell S: Potential gene therapy for cancer stem cells. Current Gene Therapy 6:579-591, 2006
13. Bucher NLR, Malt RA: Regeneration of the Liver and Kidney. Boston, MA, Little Brown and Co, 1971
14. Steiner JW, Pera AM, Taichman LB: Cell population dynamics in the liver: A review of quantitative morphological techniques applied to the study of physiological and pathological growth. Exp Mol Pathol 5:146-181, 1966
15. Sell S, Ilic Z: Liver Stem Cells. Austin, TX, Landis Bioscience, 1997
16. Higgins GM, Anderson RM: Experimental pathology of the liver: Restoration of the liver of the white rat following partial surgical removal. AMA Arch Pathol 12:186-202, 1931
17. Grisham JW: A morphologic study of deoxyribonucleic acid synthesis and cell proliferation in regenerating rat liver: Autoradiographic studies. Cancer Res 22:842-849, 1962
18. Rabes HM, Wirshing R, Ruxzek HV, et al: Analysis of cell cycle compartments of hepatocytes after partial hepatectomy. Cell Tissue Kinetics 9:517-532, 1995
19. Stowell RE, Less CS: Histochemical studies of mouse liver after single feeding of carbon tetrachloride. Arch Pathol 50:519-537, 1950
20. Wahl PN, Tandon HD, Bharadwaj TP: Acute carbon tetrachloride hepatic injury: Composite histological, histochemical and biochemical study - Part I. Histological and histochemical studies. Acta Pathol Microbiol Scand 37:305-314, 1955
21. Engelhardt NV, Baranov VN, Zareva MN, et al: Ultrastructural localization of α-fetoprotein (AFP) in regenerating mouse liver poisoned with CCl4: Reexpression of AFP in differentiated hepatocytes. Histochemistry 80:401-407, 1984
22. Seglen PO: DNA ploidy and autophagic protein degradation as determinants of hepatocellular growth and survival. Cell Biol Toxicol 13:301-315, 1997
23. Farber E: Similarities in the sequence of early histologic changes induced in the liver by ethionine, 2-acetylaminofluorene, and 3′-methyl- 4-dimethylamionazobenzene. Cancer Res 16:142-148, 1956
24. Farber E: Ethionine carcinogenesis. Adv Cancer Res 7:383-474, 1963
25. Koch KS, Leffert HL: Normal liver progenitor cells in culture, in Sell S (ed): Stem Cells Handbook. Totowa, NJ, Humana Press Inc, 2004, pp 367-384,
26. Sell S: Heterogeneity and plasticity of hepatocyte lineage cells. Hepatol 33:738-750, 2001
27. Morris HP, Wagner BP: Induction and transplantation of rat hepatomas with different growth rate (including minimal deviation hepatomas). Methods in Cancer Res IV:125-152, 1968
28. Morris HP, Meranze DR: Induction and some characteristics of "minimal deviation" and other transplantable rat hepatomas. Recent Results Cancer Res 44:103-111, 1974
29. Farber E: On the concept of minimal deviation in the study of the biochemistry of cancer. Cancer Res 28:1210-1211, 1968
30. Ono T: Enzyme patterns and malignancy of experimental hepatomas. Gann Monograph No 1:189-206, 1966
31. Sugimura T, Matsushima T, Kawachi T, et al: Molecular species of aldolases and hexokinases in experimental hepatomas. Gann Monograph No 1:143-150, 1966
32. Schapira F: Aldolase isozymes in cancer. Eur J Cancer 2:131-134, 1966
33. Matsushima T, Kawabe S, Shibuya M, et al: Alsolase isozyme in rat tumor cells. Biochem Biophys Res Comm 30:565-570, 1968
34. Sell S, Morris HP: Relationship of rat α1-fetoprotein to growth rate and chromosome composition of Morris hepatomas. Cancer Res 34:1413-, 1974
35. Potter VR: Recent trends in cancer biochemistry: The importance of studies on fetal tissue. Canadian Cancer Conf 8:9-30, 1968
36. Potter VR: Phenotypic diversity in experimental hepatomas: The concept of partially blocked ontogeny. Br J Cancer 38:1-23, 1978
37. Potter VR: The present status of the blocked ontogeny hypothesis of neoplasia: The thalassemia connection. Oncodevel Biol Med 2:243-266, 1981
38. Pitot HC: The natural history of neoplastic development: The relation of experimental models to liver cancer. Cancer 49:1206-1211, 1982
39. Scherer E: Neoplastic progression in experimental hepatocarcinogenesis. Biochim Biochim Biophys Acta 738:219-236, 1984
40. Rabes HM: Development and growth of early preneoplastic lesions induced in the liver by chemical carcinogens. J Cancer Res Clin Oncol 106:85-91, 1983
41. Bannasch P: Sequential cellular changes during chemical carcinogenesis. J Cancer Res Clin Oncol 108:11-22, 1984
42. Bannasch P, Hacker HJ, Klinek F, et al: Hepatocellular glycogenosis and related pattern of enzymatic changes during hepatocarcinogenesis. Adv Enzyme Regul 22:97-121, 1984
43. Alterman K: Hepatic neoplasia: Reflections and ruminations. Virchows Arch 427:1-18, 1995
44. Turusov VC, Deringer MI, Dunn TB, et al: Malignant mouse-liver tumors resembling human hepatoblastomas. J Natl Cancer Inst 51:1689-1695, 1973
45. Nonoyama T, Fullerton F, Reznic G, et al: Mouse hepatoblastomas: A histological study. Vet Pathol 25:286-296, 1988
46. Schmidt D, Harms D, Lang W: Primary hepatic tumours in childhood. Virchows Archiv 407:387-405, 1985
47. Kasai M, Watanabe I: Histologic classification of liver cell carcinoma in infancy and childhood and its clinical evaluation. Cancer 25:551-563, 1970
48. Haas R, Muczynski KA, Krailo M, et al: Histopathology and prognosis in childhood hepatoblastona and hepatocarcinoma. Cancer 64:1082-1095, 1989
49. Poulsen H, Christoffersen P: Abnormal bile duct epithelium in liver biopsies with histological signs of viral hepatitis. Acta Path Microbiol Scand 76:383-390, 1969
50. Uchida T, Peters RL: The nature and origin of proliferated bile ductules in alcoholic liver disease. Am J Clin Pathol 79:326-333, 1983
51. Gerber MA, Thung SN, Shen S, et al: Phenotypic characterization of hepatic proliferation: Antigen expression by proliferating epithelial cells in fetal liver, massive hepatic necrosis, and nodular transformation of the liver. AM J Pathol 110:70-74, 1983
52. Popper H: The relation of mesenchymal products to hepatic epithelial systems. Prog Liver Dis 9:27-38, 1990
53. Hsia CC, Evarts RP, Harushige N, et al: Occurrence of oval-type cells in hepatitis B virus-associated human hepatocarcinogenesis. Hepatology 16:1327-1333, 1992
54. Vos RD, Desmet V: Ultrastructural characteristics of novel epithelial cell types identified in human pathologic liver specimens with chronic ductular reaction. AM J Pathol 140:1441-1450, 1992
55. Vyberg M: The hepatitis-associated bile duct lesion. Liver 13:289-301, 1993
56. Thung SN: The development of proliferating ductular structures in liver disease. Arch Pathol Lab Med 114:407-411, 1990
57. Desmet V, Roskams T, Ban Eyken P: Ductular reaction in the liver. Pathol Res Pract 191:513-524, 1995
58. Haque S, Haruna Y, Malesnik MA, et al: Identification of bipotential progenitor cells in human liver regeneration. Lab Investig 79:699-705, 1996
59. Fiel MI, Antonio LB, Nalesnik MA, et al: Characterization of ductular hepatocytes in primary liver allograft failure. Mod Pathol 10:348-353, 1997
60. Roskams T, Vos RD, Desmet V: "Undifferentiated progenitor cells" in focal nodular hyperplasia of the liver. Histopathology 28:291-299, 1996
61. Crosby HA, Hubscher S, Fabris L, et al: Immunolocalization of putative human liver progenitor cells in livers from patients with end-stage primary biliary cirrhosis and sclerosing cholangitits using the monoclonal antibody OV-6. AM J Pathol 152:771-779, 1998
62. Roskams T, Vos RD, Eyken PV, et al: Hepatic OV-6 expression in human liver disease and rat experiments evidence for hepatic progenitor cells in man. J Hepatol 29:455-463, 1998
63. Xiao J-C, Ruck P, Kaiserling E: Small epithelial cells in extrahepatic biliary atresia: Electron microscopic and immunoelectron microscopic findings suggest a close relationship to liver progenitor cells. Histopathology 55:454-460, 1999
64. Theise ND, Saxena R, Portmann BC, et al: The canals of Hering and hepatic stem cells in humans. Hepatology 30:1425-1433, 1999
65. Falkowski O, An HJ, Ianus IA, et al: Regeneration of hepatocyte 'buds' in cirrhosis from intrabiliary stem cells. J Hepatol 39:357-364, 2003
66. Zhou H, Rogler LE, Teperman L, et al: Identification of hepatocytic and bile ductular cell lineages and dandidate stem cells in bipolar ductular reactions in cirrhotic human liver. Hepatology 45:716-724, 2007
67. Hillan KJ, Burt AD, George WE, et al: Intrasplenci hepatocytes transplantation in rats with experimental liver injury: Morphological and morphometric studies. J Pathol 159:67-73, 1989
68. Michalopoulos GK, Bowen WC, Mulè K, et al: Hepatocytes undergo phenotypic transformation to biliary epithelium in organoid cultures. Hepatology 36:278-283, 2002
69. Michalopoulos GK, Barua L, Bowen WC: Transdifferentiation of rat hepatocytes into biliary cells after bile duct ligation and toxic biliary injury. Hepatology 41:535-544, 2005
70. Sell S: Comparison of liver progenitor cells in human atypical ductular reactions with those seen in experimental models of liver injury. Hepatol 27:327-331, 1998
71. Rich JN: Cancer stem cells in radiation resistance. Cancer Res 67:8980-8984, 2007
72. Cairns J: Somatic stem cells and the kinetics of mutagenesis and carcinogenesis. Proc Natl Acad Sci U S A 99:10567-10570, 2002
73. Cairns J: Cancer and the immortal strand hypothesis. Genetics 174:1069-1072, 2006
74. Trott KR: Tumour stem cells: The biological concept and its application in cancer treatment. Radiother Oncol 30:1-5, 1994
75. Denekamp J: Tumour stem cells: Facts, interpretation and consequences. Radiother Oncol 30:6010, 1994
76. Ciba T, Ktia K, Aheng YW, et al: Side population purified from hepatocellullar carcinoma cells harbors cancer stem cell-like properties. Hepatology 44:240-251, 2006
77. Kondo T, Setoguchi T, Taga T: Persistence of a small subpopulation of cancer stem-like cells in the C6 gliona cell line. Proc Natl Acad Sci U S A 101:781-786, 2004
78. Hill RP: Identifying cancer stem cells in solid tumors: Case not proven. Cancer Res 66:1891-1895, 2006
79. Zheng X, SHen G, Yang X, et al: Most C6 cells are cancer stem cells: Evidence from clonal and population analysis. Cancer Res 67:3691-3697, 2007
80. Zen Y, Fujii T, Yoshikawa S, et al: Histological and culture studies with respect to ABCG2 expression support the existence of a cancer cell hierarchy in human hepatocellular carcinoma. Am J Path 170:1750-1762, 2007
81. Villanueva A, Newell P, Chiang DY, et al: Genomics and signaling pathways in hepatocellular carcinoma. Semin Liver Dis 27:55-76, 2007
82. Takahashi K, Tanabe K, Ohnuki M, et al: Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:834-835, 2007
83. Chung C, Yeh K-T, Hsu NC, et al: Expression of c-kit protooncogene in human hepatocellular carcinoma. Cancer Lett 217:231-236, 2005
84. GoÂrnicka B, Ziarkiewicz-WroÂblewska B, Michalowicz B, et al: Immature hepatic tumor of bimodal differentiation in a young adult patient: A novel lesion expressing β-catenin and mimicking a distinct phase of hepatogenesis. J Hepatol 34:955-961, 2001
85. Glinsky G: Genomic models of metastatic cancer. Cell Cycle 5:11-23, 2006
86. Chiba T, Zheng YW, Kita K, et al: Enhanced self-renewal capability in hepatic stem/progenitor cells drives cancer initiation. Gastroenterology 133:937-950, 2007
87. Apte U, Thompson MD, Cui S, et al: Wnt/beta-catenin signaling mediates oval cell response in rodents. Hepatology 2007 Oct 10; [Epub ahead of print]
88. Roundtree CB, Barsky L, Ge S, et al: A CD133 expressing murine liver oval cell population with bi-lineage potential. Stem Cells 25:2419-2429, 2007
89. Ma S, Chan KW, Hu L, et al: Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology 132:2542-2556, 2007
90. Ma S, Lee TK, Zheng B-J, et al: CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway. Oncogene 27:1749-1758, 2008
91. Fang AF, Ngai P, Ho DW, et al: Identification of local and circulating cancer stem cells in human liver cancer. Hepatology 47:919-928, 2008
92. Yan AF, Ho DW, Ng MN, et al: Significance of CD90+ cancer stem cells in human liver cancer. Cancer Cell 13:153-166, 2008
93. Yamashita T, Forgues M, Wang W, et al: EpCAM and α-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma. Cancer Res 68:1451-1461, 2008